Xencor (XNCR) Net Cash Flow (QoQ) (2013 - 2026)
Xencor (XNCR) Net Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Xencor | 1.50 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -255.14% |
| Dec 31, 2025 | 259.66% |
| Sep 30, 2025 | -438.62% |
| Jun 30, 2025 | 466.00% |
| Mar 31, 2025 | -111.00% |
| Dec 31, 2024 | 782.37% |
| Sep 30, 2024 | -557.58% |
| Jun 30, 2024 | 98.84% |
| Mar 31, 2024 | -2,248.63% |
| Dec 31, 2023 | -94.24% |
| Sep 30, 2023 | 148.83% |
| Jun 30, 2023 | -304.23% |
| Mar 31, 2023 | 1,332.61% |
| Dec 31, 2022 | -60.30% |
| Sep 30, 2022 | 111.24% |
| Jun 30, 2022 | 55.75% |
| Mar 31, 2022 | -163.76% |
| Dec 31, 2021 | 237.03% |
| Sep 30, 2021 | -22.12% |
| Jun 30, 2021 | -555.43% |